Sanofi has become the latest Big…
Sanofi has become the latest Big Pharma to freeze R&D [...]
AstraZeneca has paused a 200…
AstraZeneca has paused a 200 million pound sterling (about $271 [...]
Eli Lilly is reconsidering plans…
Eli Lilly is reconsidering plans for its U.K. biotech-focused Gateway [...]
Maryland-based biotech Galimedix…
Maryland-based biotech Galimedix Therapeutics is ready to take a big [...]
With its head of U.S. business…
With its head of U.S. business Julie Kim sliding up [...]
FibroGen has agreed to pay $1.25…
FibroGen has agreed to pay $1.25 million to the Securities [...]
Capsida Biotherapeutics has paused…
Capsida Biotherapeutics has paused a gene therapy clinical trial after [...]
LB Pharmaceuticals’ decision to…
LB Pharmaceuticals’ decision to break cover and go public seems [...]
Less than two years after breaking…
Less than two years after breaking ground on a ballyhooed [...]
One week after warning that the…
One week after warning that the United Kingdom is undervaluing [...]